Table of Contents
ISRN Ophthalmology
Volume 2012 (2012), Article ID 902819, 7 pages
http://dx.doi.org/10.5402/2012/902819
Research Article

Patient Race, Reported Problems in Using Glaucoma Medications, and Adherence

1Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
2Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, CB No. 7590, Chapel Hill, NC 27599-7590, USA
3Health Economics and Outcomes Research, Alcon Research Ltd., Fort Worth, TX, USA
4Departments of Pediatrics and Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
5Department of Ophthalmology, School of Medicine, Duke University and Durham VA Medical Center, Health Services Research and Development, Durham, NC, USA
6Department of International Health, Bloomberg School of Public Health and Department of Ophthalmology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
7University of Maryland School of Medicine, Baltimore, MD, USA

Received 30 August 2012; Accepted 8 October 2012

Academic Editors: M. Baskaran and K. Wu

Copyright © 2012 Betsy Sleath et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. A. Quigley and A. T. Broman, “The number of people with glaucoma worldwide in 2010 and 2020,” British Journal of Ophthalmology, vol. 90, no. 3, pp. 262–267, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. P. R. Lichter, D. C. Musch, B. W. Gillespie et al., “Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery,” Ophthalmology, vol. 108, no. 11, pp. 1943–1953, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Sleath, A. L. Robin, D. Covert, J. E. Byrd, G. Tudor, and B. Svarstad, “Patient-reported behavior and problems in using glaucoma medications,” Ophthalmology, vol. 113, no. 3, pp. 431–436, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. B. L. Nordstrom, D. S. Friedman, E. Mozaffari, H. A. Quigley, and A. M. Walker, “Persistence and adherence with topical glaucoma therapy,” American Journal of Ophthalmology, vol. 140, no. 4, pp. 598.e1–598.e11, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. G. F. Schwartz, R. Platt, G. Reardon, and M. A. Mychaskiw, “Accounting for restart rates in evaluating persistence with ocular hypotensives,” Ophthalmology, vol. 114, no. 4, pp. 648–652, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. D. S. Friedman, C. O. Okeke, H. D. Jampel et al., “Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma,” Ophthalmology, vol. 116, no. 6, pp. 1097–1105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. C. Patel and G. L. Spaeth, “Compliance in patients prescribed eyedrops for glaucoma,” Ophthalmic Surgery, vol. 26, no. 3, pp. 233–236, 1995. View at Google Scholar · View at Scopus
  8. K. W. Muir, C. Santiago-Turla, S. S. Stinnett et al., “Health literacy and adherence to glaucoma therapy,” American Journal of Ophthalmology, vol. 142, no. 2, pp. 223–226, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Sleath, R. Ballinger, D. Covert, A. L. Robin, J. E. Byrd, and G. Tudor, “Self-reported prevalence and factors associated with nonadherence with glaucoma medications in veteran outpatients,” American Journal Geriatric Pharmacotherapy, vol. 7, no. 2, pp. 67–73, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Sleath, S. J. Blalock, J. L. Stone et al., “Validation of a short version of the glaucoma medication self-efficacy questionnaire,” British Journal of Ophthalmology, vol. 96, no. 2, pp. 258–262, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. C. A. Melfi, T. W. Croghan, M. P. Hanna, and R. L. Robinson, “Racial variation in antidepressant treatment in a Medicaid population,” Journal of Clinical Psychiatry, vol. 61, no. 1, pp. 16–21, 2000. View at Google Scholar · View at Scopus
  12. J. A. Krishnan, G. B. Diette, E. A. Skinner, B. D. Clark, D. Steinwachs, and A. W. Wu, “Race and sex differences in consistency of care with National Asthma Guidelines in managed care organizations,” Archives of Internal Medicine, vol. 161, no. 13, pp. 1660–1668, 2001. View at Google Scholar · View at Scopus
  13. M. Monane, R. L. Bohn, J. H. Gurwitz, R. J. Glynn, R. Levin, and J. Avorn, “Compliance with antihypertensive therapy among elderly medicaid enrollees: the roles of age, gender, and race,” American Journal of Public Health, vol. 86, no. 12, pp. 1805–1808, 1996. View at Google Scholar · View at Scopus
  14. N. Congdon, “Causes and prevalence of visual impairment among adults in the United States,” Archives of Ophthalmology, vol. 122, no. 4, pp. 477–485, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. C. O. Okeke, H. A. Quigley, H. D. Jampel et al., “Adherence with topical glaucoma medication monitored electronically. The travatan dosing aid study,” Ophthalmology, vol. 116, no. 2, pp. 191–199, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. A. L. Robin, G. D. Novack, D. W. Covert, R. S. Crockett, and T. S. Marcic, “Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use,” American Journal of Ophthalmology, vol. 144, no. 4, pp. 533–540, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Osterberg and T. Blaschke, “Adherence to medication,” New England Journal of Medicine, vol. 353, no. 5, pp. 487–497, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Sleath, S. Blalock, D. Covert et al., “The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity,” Ophthalmology, vol. 118, no. 12, pp. 2398–2402, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Sleath, S. J. Blalock, A. Robin et al., “Development of an instrument to measure glaucoma medication self-efficacy and outcome expectations,” Eye, vol. 24, no. 4, pp. 624–631, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. D. L. Roter, J. A. Hall, R. Merisca, B. Nordstrom, D. Cretin, and B. Svarstad, “Effectiveness of interventions to improve patient cmpliance a meta-analysis,” Medical Care, vol. 36, no. 8, pp. 1138–1161, 1998. View at Google Scholar · View at Scopus
  21. R. B. Haynes, H. P. McDonald, and A. X. Garg, “Helping patients follow prescribed treatment: clinical applications,” Journal of the American Medical Association, vol. 288, no. 22, pp. 2880–2883, 2002. View at Publisher · View at Google Scholar · View at Scopus